Phage therapy program
Micreos Pharmaceuticals AG / Micreos Group
| Status | Research/development |
|---|---|
| Type | Company |
| Location | Baar / Zurich; Bilthoven group activity; Switzerland; Netherlands |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | Corporate scientific/partner contact; no clinical patient intake established. |
|---|---|
| Areas of work | Engineered endolysins, including MEndoB for S. aureus-associated atopic dermatitis; phage-derived enzymes rather than live therapeutic phage preparations. |
| International access | No current clinical or international patient route established. |
What to confirm
- Do not present Gladskin consumer products or Phageguard food-safety phages as clinical live-phage treatment.
- The exact requested name PhagoBio was not linked to a verified current human-phage provider.
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | eu-micreos |
|---|